Skip to main content

Table 3 Schedule for data collection during the GOSPEL 1 trial

From: Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

 

Study period

 

Enrolment

Allocation

Post-allocation

Close-out

Timepoint

Pre-baseline

Baseline

Baseline

6 months*

12 months*

18 months

Enrolment

 Eligibility screen

X

     

 Informed consent

X

     

 Allocation

 

X

    

Interventions

 GOSPEL 1

      

 Usual care

      

Outcomes

 Recruitment (feasibility)

    

X

 

 Barriers and facilitators of care: optional interviews (feasibility)

    

X

 

 Satisfaction of care

    

X

 

 Medications history

  

X

   

 HRQoL (FACT-Lym)

  

X

X

X

 

 Patient experience of care

  

X

X

X

 

 Symptom distress

  

X

X

X

 

 Comorbidity burden

  

X

 

X

 

 Dietary intake

  

X

X

X

 

 Physical activity

  

X

X

X

 

 Financial distress

  

X

X

X

 

 Employment interference

  

X

X

X

 

Participant characteristics

 Demographics

  

X

   

 Clinical characteristics

  

X

   

Process Outcomes

 Intervention fidelity: completion of checklists

     

X

 Clinical encounters at cancer center

     

X

 Cost analysis: resources to conduct the intervention

     

X

 Safety indicators: clinical encounters, unscheduled clinic visits and rapid referrals back to acute care

     

X

  1. *Post-baseline